Verve Therapeutics
(NASDAQ:VERV)
$15.63
0.35[2.29%]
At close: Jul 1
$15.63
00
After Hours: 4:04PM EDT
Day High/Low15.2 - 16.01
52 Week High/Low10.7 - 78
Open / Close15.31 / 15.63
Float / Outstanding20.7M / 48.7M
Vol / Avg.485.2K / 693.6K
Mkt Cap760.6M
P/E-
50d Avg. Price14.26
Div / Yield-
Payout Ratio-
EPS-0.62
Total Float20.7M

Verve Therapeutics (NASDAQ:VERV), Quotes and News Summary

Verve Therapeutics (NASDAQ: VERV)

Day High/Low15.2 - 16.01
52 Week High/Low10.7 - 78
Open / Close15.31 / 15.63
Float / Outstanding20.7M / 48.7M
Vol / Avg.485.2K / 693.6K
Mkt Cap760.6M
P/E-
50d Avg. Price14.26
Div / Yield-
Payout Ratio-
EPS-0.62
Total Float20.7M
load more
Sector: Health Care.Industry: Biotechnology
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.620
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Verve Therapeutics Questions & Answers

Q
How do I buy Verve Therapeutics (VERV) stock?
A

You can purchase shares of Verve Therapeutics (NASDAQ: VERV) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Verve Therapeutics's (VERV) competitors?
Q
What is the target price for Verve Therapeutics (VERV) stock?
A

The latest price target for Verve Therapeutics (NASDAQ: VERV) was reported by BMO Capital on Friday, June 17, 2022. The analyst firm set a price target for 48.00 expecting VERV to rise to within 12 months (a possible 207.10% upside). 7 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Verve Therapeutics (VERV)?
A

The stock price for Verve Therapeutics (NASDAQ: VERV) is $15.63 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Verve Therapeutics (VERV) pay a dividend?
A

There are no upcoming dividends for Verve Therapeutics.

Q
When is Verve Therapeutics (NASDAQ:VERV) reporting earnings?
A

Verve Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Verve Therapeutics (VERV) going to split?
A

There is no upcoming split for Verve Therapeutics.

Q
What sector and industry does Verve Therapeutics (VERV) operate in?
A

Verve Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.